Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: a randomised trial
We provide detailed injection training and help you determine the right dose based on your response
Zhang YP, Eber A, Yuan Y, et al
In trials and real-world experience, people have used GLP-1 medications safely for many years
By Type The GLP-1 receptor agonist market is segmented by drug class into: a) Liraglutide b) Semaglutide c) Tirzepatide d) Dulaglutide e) Other Drugs By Route Of Administration The GLP-1 receptor agonist market is segmented by route of administration into: a) Parenteral b) Oral By End-User The GLP-1 receptor agonist market is segmented by end-user into: a) Hospitals b) Surgical Clinics c) Other End-Users By Geography - The GLP-1 receptor agonist market is segmented by geography into: China India Japan Australia Indonesia South Korea USA Canada Brazil France Germany UK Italy Spain Russia o Asia Pacific o Africa GLP-1 Receptor Agonist Market Drivers The key drivers of the GLP-1 receptor agonist market include: Rise In Obesity Rates During the forecast period, the rise in obesity rates will propel the growth of the GLP-1 receptor agonist market
US$ 24.85
US$ 23.10
US$ 29.34
US$ 25.76
